Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis

Research output: Contribution to journalArticle

7 Citations (Scopus)
Original languageEnglish
Pages (from-to)343-346
Number of pages4
JournalEndocrinology
Volume155
Issue number2
DOIs
Publication statusPublished - Feb 2014

ASJC Scopus subject areas

  • Endocrinology

Cite this

@article{52780cf3595a4b05af9b9edf1d96eb9d,
title = "Commentary: FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis",
author = "Anna Alisi and Nadia Panera and Valerio Nobili",
year = "2014",
month = "2",
doi = "10.1210/en.2013-1828",
language = "English",
volume = "155",
pages = "343--346",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "2",

}

TY - JOUR

T1 - Commentary

T2 - FGF21 holds promises for treating obesity-related insulin resistance and hepatosteatosis

AU - Alisi, Anna

AU - Panera, Nadia

AU - Nobili, Valerio

PY - 2014/2

Y1 - 2014/2

UR - http://www.scopus.com/inward/record.url?scp=84893157935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893157935&partnerID=8YFLogxK

U2 - 10.1210/en.2013-1828

DO - 10.1210/en.2013-1828

M3 - Article

C2 - 24248463

AN - SCOPUS:84893157935

VL - 155

SP - 343

EP - 346

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 2

ER -